Why Is Hims & Hers Health Stock Falling Tuesday?

Hims & Hers Health Inc. (NYSE: HIMS ) stock fell Tuesday after the company reported mixed second-quarter results following Monday's closing bell. Nasdaq futures rose 0.28%, while S&P 500 futures gained 0.16%. Concerns over shrinking profit margins overshadowed strong subscriber growth and a higher annual revenue forecast, The company's push into branded GLP-1 weight-loss drugs and international markets drove up costs, contributing to a quarterly loss compared with a profit a year earlier. Hims & Hers Health reported quarterly losses of 37 cents per share. The performance missed the analyst consensus estimate for losses of three cents per share. Top-Line Revenue Growth Quarterly revenue reached $753.21 million, which beat the Street estimate of $699.889 million. The revenue figure increased from $544.83 million reported in the same period last year. Inside...